PHOENIX Pharma SE

The PHOENIX group, headquartered in Mannheim, is a leading pharmaceutical trader in Europe. Active in 27 countries, the company offers unique geographical coverage throughout Europe, making a vital contribution to comprehensive healthcare with more than 37,000 employees. The PHOENIX group’s vision is to be the best integrated healthcare provider – wherever it is active.

The PHOENIX group considers itself to be a link between manufacturer and patient. Pharmaceutical manufacturers, pharmacies, doctors, hospitals, health insurance funds, and patients across Europe can benefit from our service offering. In pharmaceutical wholesale, the PHOENIX group is active with 163 distribution centres in 27 countries and supplies pharmacies and medical institutions with drugs and other health products. Numerous other products and services for pharmacy customers complete the portfolio – from support with patient advice to modern goods management systems to pharmacy cooperation programmes. With (...)

PHOENIX group has been actively involved in the Falsified Medicines Directive (FMD) and its Delegated Regulation (EU) 2016/161. Via the European body representing pharmaceutical full line wholesalers, GIRP, PHOENIX has supported both the European associations and the European institutions in understanding better the impact such legislation has on the pharmaceutical wholesale sector. PHOENIX has provided factual examples that helped shape the drafting of the Delegated Regulation. Following the publishing of the legislation, PHOENIX is constantly involved in the implementation process together with the other supply chain partners and their representative bodies at European level (EFPIA, PGEU, Medicines for Europe and EAEPC) , contributing to the clarifications of various topics with regard to FMD implementation.

Besides FMD, PHOENIX has been supported the drafting by the Commission of the Good Distribution Practice (GDP) guidelines. Other initiatives where PHOENIX group was involved refer to Commission working groups on e-health and active and healthy ageing and participation in numerous European Parliament debates concerning the healthcare sector.

1

0.25

None declared

Data not provided by Register Secretariat due to GDPR

Data not provided by Register Secretariat due to GDPR

II - In-house lobbyists and trade/business/professional associations

Companies & groups